Medscape1h
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
NPR13d
Medicare targets 15 more drugs for price negotiations — including Ozempic
The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...
verywellhealth14d
How Quickly Does Klonopin Begin to Work? Expert Insights Explained
Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...
Wane14d
Biden administration picks 15 more drugs for Medicare negotiation
(The Hill) — The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration ...
Associated Press14d
Ozempic, Wegovy and other drugs are among 15 selected for Medicare’s price negotiations
Copyright 2025 The Associated Press. All Rights Reserved. President Joe Biden speaks about prescription drug costs at the National Institutes of Health in Bethesda ...